176 related articles for article (PubMed ID: 18766166)
1. Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients.
El-Akawi ZJ; Al-Hindawi FK; Bashir NA
Neuro Endocrinol Lett; 2008 Aug; 29(4):482-4. PubMed ID: 18766166
[TBL] [Abstract][Full Text] [Related]
2. The importance of alpha-1 antitrypsin (alpha1-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients.
El-Akawi ZJ; Abu-Awad AM; Sharara AM; Khader Y
Neuro Endocrinol Lett; 2010; 31(1):113-6. PubMed ID: 20150872
[TBL] [Abstract][Full Text] [Related]
3. Alpha-1 antitrypsin phenotypes in patients with lung, prostate and breast cancer.
El-Akawi ZJ; Al-Hindawi FK
Saudi Med J; 2004 Feb; 25(2):186-9. PubMed ID: 14968215
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of alpha1-antitrypsin and alpha2-macroglobulin in lung cancer.
Micksche M; Kokron O
Osterr Z Onkol; 1977; 3(5-6):116-9. PubMed ID: 67586
[TBL] [Abstract][Full Text] [Related]
5. Altered carbohydrate content of alpha1-antitrypsin in patients with cancer.
Rostenberg I; Guízar-Vázquez J; Peñaloza R
J Natl Cancer Inst; 1978 Oct; 61(4):961-5. PubMed ID: 309009
[TBL] [Abstract][Full Text] [Related]
6. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
[TBL] [Abstract][Full Text] [Related]
7. [Relations between serum apha-antitrypsin level and neoplasms].
Apicella C; Carniato A; Ippoliti F; Romano V; Tomai A; Ferrari S
Arch Sci Med (Torino); 1976; 133(2):103-8. PubMed ID: 1087553
[TBL] [Abstract][Full Text] [Related]
8. Relationship between alpha-1 antitrypsin deficient genotypes S and Z and lung cancer in Jordanian lung cancer patients.
El-Akawi ZJ; Nusier MK; Zoughool FE
Saudi Med J; 2006 Feb; 27(2):181-4. PubMed ID: 16501672
[TBL] [Abstract][Full Text] [Related]
9. [Serum haptoglobin and alpha-1 antitrysin levels as biological evolution markers in patients with gastric and colorectal cancer].
Kovcić V; Jelić S; Filipović I; Tomasević Z
Srp Arh Celok Lek; 1994; 122(11-12):311-3. PubMed ID: 17974404
[TBL] [Abstract][Full Text] [Related]
10. [Serum A1-antitrypsin levels in prostate pathology].
Dokrunova AA; Sokolova OS
Urologiia; 2012; (5):77-80. PubMed ID: 23342621
[TBL] [Abstract][Full Text] [Related]
11. Alpha-1-antitrypsin levels and genetic variation of the alpha-1-antitrypsin gene in Peyronie's disease.
Hauck EW; Hauptmann A; Haag SM; Bohnert A; Weidner W; Bein G; Hackstein H
Eur Urol; 2004 Nov; 46(5):623-8; discussion 628. PubMed ID: 15474273
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.
Pazdiora P; Svobodova S; Fuchsova R; Kucera R; Prazakova M; Vrzalova J; Narsanska A; Strakova M; Treskova I; Pecen L; Treska V; Holubec L; Pesek M; Finek J; Topolcan O
Anticancer Res; 2011 Oct; 31(10):3619-21. PubMed ID: 21965787
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma levels of serine proteinase inhibitors in lung cancer patients.
Zelvyte I; Wallmark A; Piitulainen E; Westin U; Janciauskiene S
Anticancer Res; 2004; 24(1):241-7. PubMed ID: 15015603
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
Lang T; Mühlbauer M; Strobelt M; Weidinger S; Hadorn HB
Eur J Med Res; 2005 Dec; 10(12):509-14. PubMed ID: 16356865
[TBL] [Abstract][Full Text] [Related]
15. Thyroid function and cancer risk: a prospective population study.
Hellevik AI; Asvold BO; Bjøro T; Romundstad PR; Nilsen TI; Vatten LJ
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):570-4. PubMed ID: 19155436
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the clinical significance of antigenic and functional levels of α1-proteinase inhibitor (α1-Pi) in infiltrating ductal breast carcinomas.
Anes AB; Nasr HB; Hammann P; Kuhn L; Trimeche M; Hamrita B; Bougmiza I; Chaieb A; Khairi H; Chahed K
Clin Biochem; 2012 Nov; 45(16-17):1421-31. PubMed ID: 22841602
[TBL] [Abstract][Full Text] [Related]
17. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
Di Martino G; Iannucci F; Bizzarro A; Iacono G
Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
[TBL] [Abstract][Full Text] [Related]
18. [alpha 1-proteinase inhibitor in breast cancer].
Demidov VP; Iakubovskaia RI; Karmakova TA; Avdeev GI; Komissarov AB; Sorokin EE; Kotova TS
Vopr Onkol; 1990; 36(1):23-9. PubMed ID: 2106187
[TBL] [Abstract][Full Text] [Related]
19. Alfa-antitrypsin increase in lung cancer.
Daddi G; Mancini PA; Parola D; Contini A
Boll Ist Sieroter Milan; 1976; 55(6):510-2. PubMed ID: 1088073
[TBL] [Abstract][Full Text] [Related]
20. [Assay of "pregnancy alpha 2 glycoprotein" in the serum of prostatic cancer patients and changes during estrogen therapy].
Lanson Y; Lanson M; Gutman N; Muh JP
J Urol Nephrol (Paris); 1979 Jun; 85(6):399-407. PubMed ID: 90738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
